- Conditions
- Actinic Keratosis
- Interventions
- KX2-391 Ointment
- Drug
- Lead sponsor
- Athenex, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 29 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 1
- States / cities
- Austin, Texas
Source: ClinicalTrials.gov public record
Updated Jul 5, 2018 · Synced May 21, 2026, 5:34 PM EDT